Biomedical Engineering Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Colorectal Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method
Conditions: Colorectal Cancer; Organoids Sponsors: Funan Liu; Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences; Precedo Pharmaceuticals Co. Ltd.; Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
A Clinical Study Aims to Assess the Consistency of Clinical Efficacy in Gastric Cancer Treatment and Drug Susceptibility Outcomes Using a Novel Drug Susceptibility Testing Method
Conditions: Gastric Cancer; Organoids Sponsors: Funan Liu; Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences; Precedo Pharmaceuticals Co. Ltd.; Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou 215163, China Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials
Cladribine vs Placebo for Non-active Progressive Multiple Sclerosis (CLASP-MS).
Conditions: Multiple Sclerosis, Secondary Progressive; Multiple Sclerosis Interventions: Drug: Cladribine Subcutaneous Injection; Drug: 0.9% Chloride Injection Sodium Sponsors: Institute of Psychiatry and Neurology, Warsaw; Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences; Mossakowski Medical Research Centre Polish Academy of Sciences; Poznan University of Medical Sciences; Military Institute of Aviation Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 27, 2023 Category: Research Source Type: clinical trials
Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma
Condition: Liver Cirrhosis Intervention: Diagnostic Test: multiple reaction monitoring (MRM)-based multimarker panel Sponsors: Seoul National University Hospital; Youngsoo Kim, Ph.D., Department of Biomedical Engineering, Seoul National University College of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2023 Category: Research Source Type: clinical trials